SEC Form 4 · accession 0001209191-16-139166
BELDEN INC. · BDC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henk Derksen
Officer — SVP, Finance, & CFO
Period of report
Aug 29, 2016
Accepted (ET)
Aug 30, 2016 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000913142
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 29, 2016 | M | 1,800 | $47.705 | A | 20,137 | D | |
| Common StockF1 | Aug 29, 2016 | D | 1,371 | $74.31 | D | 18,766 | D | |
| Common Stock | Aug 29, 2016 | M | 8,400 | $40.96 | A | 27,166 | D | |
| Common StockF2 | Aug 29, 2016 | D | 5,888 | $74.31 | D | 21,278 | D | |
| Common Stock | Aug 29, 2016 | M | 1,868 | $11.92 | A | 23,146 | D | |
| Common StockF3 | Aug 29, 2016 | D | 929 | $74.31 | D | 22,217 | D | |
| Common Stock | Aug 29, 2016 | M | 13,768 | $21.70 | A | 35,985 | D | |
| Common StockF4 | Aug 29, 2016 | D | 8,695 | $74.31 | D | 27,290 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF5 | $47.705 | Aug 29, 2016 | M | 1,800 | D | — | Feb 21, 2017 | Common Stock | 1,800 | 0 | D |
| Stock Appreciation RightsF6 | $40.96 | Aug 29, 2016 | M | 8,400 | D | — | Feb 20, 2018 | Common Stock | 8,400 | 0 | D |
| Stock Appreciation Rights | $11.92 | Aug 29, 2016 | M | 1,868 | D | Feb 24, 2012 | Feb 24, 2019 | Common Stock | 1,868 | 0 | D |
| Stock Appreciation RightsF7 | $21.70 | Aug 29, 2016 | M | 13,768 | D | — | Feb 22, 2020 | Common Stock | 13,768 | 0 | D |
Explanation of responses
- F1This represents the difference between the number of SARs exercised (1,800) and the number of shares issued as a result of the exercise (429). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($74.31) and the exercise price ($47.705). Additional shares are then withheld to satisfy the Company's tax withholding obligations.
- F2This represents the difference between the number of SARs exercised (8,400) and the number of shares issued as a result of the exercise (2,512). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($74.31) and the exercise price ($40.96). Additional shares are then withheld to satisfy the Company's tax withholding obligations.
- F3This represents the difference between the number of SARs exercised (1,868) and the number of shares issued as a result of the exercise (939). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($74.31) and the exercise price ($11.92). Additional shares are then withheld to satisfy the Company's tax withholding obligations.
- F4This represents the difference between the number of SARs exercised (13,768) and the number of shares issued as a result of the exercise (5,073). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($74.31) and the exercise price ($21.70). Additional shares are then withheld to satisfy the Company's tax withholding obligations.
- F5600 SARs became exercisable on February 21, 2008, 600 SARs became exercisable on February 21, 2009 and 600 SARs became exercisable on February 21, 2010.
- F62,800 SARs became exercisable on February 20, 2009, 2,800 SARs became exercisable on February 20, 2010 and 2,800 SARs became exercisable on February 20, 2011.
- F76,884 SARs became exercisable on February 22, 2012 and 6,884 SARs became exercisable on February 22, 2013.